---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-070603"
form_type: "8-K"
ticker: "SANA"
cik: "0001770121"
company_name: "Sana Biotechnology, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:38:33.083697+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Sana Biotechnology shareholders elect all three Class III directors and ratify EY as auditor

## Summary
- Joshua H. Bilenker, M.D. elected with ~149M votes for, ~16M withheld.
- Richard Mulligan, Ph.D. elected with ~149.6M votes for, ~14.9M withheld.
- Mary Agnes (Maggie) Wilderotter elected with ~144.2M votes for, ~20.3M withheld.
- Ratification of Ernst & Young LLP as independent auditor for FY2024 passed with ~178.5M for, ~65K against.
- Annual meeting held June 6, 2024; all proposals approved as recommended.

## SEC filing metadata
- accession: 0000950170-24-070603
- form_type: 8-K
- ticker: SANA
- cik: 0001770121
- company_name: Sana Biotechnology, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770121/000095017024070603/0000950170-24-070603-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770121/000095017024070603/sana-20240606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-070603
- JSON: https://secwatch.observer/filing/0000950170-24-070603.json
- Plain text: https://secwatch.observer/filing/0000950170-24-070603.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.